Abstract
Over the past two decades, Meltrex® has evolved from being a novel processing technique into a comprehensive manufacturing technology. This chapter discusses the successful application of Meltrex® in the commercial development of delivery systems for varied drugs such as lopinavir (Kaletra®), ritonavir (Norvir®), ibuprofen, and verapamil hydrochloride (Isoptin®). Besides the commercial applications, Meltrex® can be successfully applied in design of solid dispersions (bioavailability enhancement of poorly soluble drugs), alter or control dissolution profiles (sustained release), reduced dosing frequency, deter substance abuse, improve safety, and efficacy of drugs. Moreover, continuous processing, rigorous and comprehensive regulatory documentation, and use of generally regarded as safe (GRAS) material are some of the striking features which make Meltrex® a popular drug delivery technology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AbbVie Deutschland GmbH & Co (2012) SOLIQS Global Drug Delivery Business, Germany. www.soliqs.com Accessed Nov 2012
Andrews GP, Abu-Diak O et al (2010) Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol 62(11):1580–1590
Bosch (2012) Technical literature on BOSCH hot melt extrusion lineWCF, BPK, BCK. Robert Bosch GmbH, Packaging Technology Division, Germany. www.boschconfectionery.com
Breitenbach J (2002) Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 54(2):107–117
Breitenbach J (2006) Melt extrusion can bring new benefits to HIV therapy: the example of Kaletra® Tablets. Am J Drug Deliv 4(2):61–64
Breitenbach J, Lewis J (2008) Two concepts, one technology: controlled-release solid dispersions using melt extrusion (Meltrex®). In: Rathbone MJ, Roberts MS (eds) Modified-release drug delivery technology. Informa Healthcare, New York, pp 179–186
Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281–1302. doi: 10.1002/jps.2600600902
Crowley MM, Zhang F et al (2007) Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 33(9):909–926
Croxtall JD, Perry CM (2010) Lopinavir/ritonavir: a review of its use in the management of HIV-1 infection. Drugs 70(14):1885–915
Cvetkovic RS, Goa KL (2003) Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs 63(8):769–802
Feng J, Xu L et al (2011) Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm 38(6):735–743
Janssens S, Van den Mooter G (2009) Review: physical chemistry of solid dispersions. J Pharm Pharmacol 61(12):1571–1586
Klein CE, Chiu YL et al (2007) The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. J Acquir Immune Defic Syndr 44(4):401–410
Klueglich M, Ring A et al (2005) Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. J Clin Pharmacol 45(9):1055–1061
Lakshman JP, Cao Y et al (2008) Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm 5(6):994–1002
Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50(1):47–60
Liu X, Lu M et al (2012) Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res 29(3):806–817
Oldfield V, Plosker GL (2006) Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs 66(9):1275–1299
Repka MA, Majumdar S et al (2008) Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv 5(12):1357–1376
Roth W, Setnik B et al (2009) Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation. Int J Pharm 368(1–2):72–75
Sakurai A, Sakai T et al (2012) Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study. Chem Pharm Bull (Tokyo) 60(4):459–464
Serajuddin AT (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88(10):1058–1066
Shah S, Maddineni S et al (2012) Melt extrusion with poorly soluble drugs. Int J Pharm S0378–S5173(12):00990–00998
Tho I, Liepold B et al (2010) Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci 40(1):25–32
von Hentig N (2007) Lopinavir/ritonavir: appraisal of its use in HIV therapy. Drugs Today (Barc) 43(4):221–247
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Shah, S., Breitenbach, J. (2013). Melt Extrusion: A Commercial Perception to Practicality. In: Repka, M., Langley, N., DiNunzio, J. (eds) Melt Extrusion. AAPS Advances in the Pharmaceutical Sciences Series, vol 9. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8432-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8432-5_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8431-8
Online ISBN: 978-1-4614-8432-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)